New Bispecific Shrinks NRG1 Fusion-Positive Lung, Pancreatic Tumors

(MedPage Today)-Zenocuzuzumab (Bizengri), which is an anti-anti-Her2 and Her3 anti-3 body, showed an effectiveness in patients with positive NRG1 cancer, especially NSCLC and pancreatic cancer, according to flammation …